Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sars-Cov-2 Infection Might Be a Predictor of Mortality in Intracerebral Hemorrhage Publisher Pubmed



Mowla A1 ; Shakibajahromi B2 ; Shahjouei S3 ; Baharvahdat H4 ; Harandi AA5 ; Rahmani F6 ; Mondello S7 ; Rahimian N8 ; Cernigliaro A9 ; Hokmabadi ES10 ; Ebrahimzadeh SA11 ; Ramezani M12 ; Mehrvar K13 ; Farhoudi M10 Show All Authors
Authors
  1. Mowla A1
  2. Shakibajahromi B2
  3. Shahjouei S3
  4. Baharvahdat H4
  5. Harandi AA5
  6. Rahmani F6
  7. Mondello S7
  8. Rahimian N8
  9. Cernigliaro A9
  10. Hokmabadi ES10
  11. Ebrahimzadeh SA11
  12. Ramezani M12
  13. Mehrvar K13
  14. Farhoudi M10
  15. Naderi S14
  16. Fenderi SM4
  17. Pishjoo M4
  18. Alizada O15
  19. Purroy F16
  20. Requena M17
  21. Tsivgoulis G18
  22. Zand R3

Source: Journal of the Neurological Sciences Published:2023


Abstract

Background: SARS-CoV-2 infection may be associated with uncommon complications such as intracerebral hemorrhage (ICH), with a high mortality rate. We compared a series of hospitalized ICH cases infected with SARS-CoV-2 with a non-SARS-CoV-2 infected control group and evaluated if the SARS-CoV-2 infection is a predictor of mortality in ICH patients. Methods: In a multinational retrospective study, 63 cases of ICH in SARS-CoV-2 infected patients admitted to 13 tertiary centers from the beginning of the pandemic were collected. We compared the clinical and radiological characteristics and in-hospital mortality of these patients with a control group of non-SARS-CoV-2 infected ICH patients of a previous cohort from the country where the majority of cases were recruited. Results: Among 63 ICH patients with SARS-CoV-2 infection, 23 (36.5%) were women. Compared to the non-SARS-CoV-2 infected control group, in SARS-CoV-2 infected patients, ICH occurred at a younger age (61.4 ± 18.1 years versus 66.8 ± 16.2 years, P = 0.044). These patients had higher median ICH scores ([3 (IQR 2–4)] versus [2 (IQR 1–3)], P = 0.025), a more frequent history of diabetes (34% versus 16%, P = 0.007), and lower platelet counts (177.8 ± 77.8 × 109/L versus 240.5 ± 79.3 × 109/L, P < 0.001). The in-hospital mortality was not significantly different between cases and controls (65% versus 62%, P = 0.658) in univariate analysis; however, SARS-CoV-2 infection was significantly associated with in-hospital mortality (aOR = 4.3, 95% CI: 1.28–14.52) in multivariable analysis adjusting for potential confounders. Conclusion: Infection with SARS-CoV-2 may be associated with increased odds of in-hospital mortality in ICH patients. © 2022
Other Related Docs
5. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
12. Neurological Involvements in Covid-19: A Hospital-Based Study, Iranian Journal of Child Neurology (2023)